Christine Feierabend

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “AB016. Phase 2 clinical trial of PT-112 in patients with thymic epithelial tumors”.

AB016. Phase 2 clinical trial of PT-112 in patients with thymic epithelial tumors

Mediastinum(2023)10.21037/med-23-ab016

N/A

0DataRank · unranked

3 citations

Shannon Swift, Renee N. Donahue, Carolina Celades, Yo-Ting Tsai, Molly A. Bingham +14 more

781 A phase II, open-label trial of bintrafusp alfa (M7824) in subjects with thymoma and thymic carcinoma (trial in progress)

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0781

N/A

0DataRank · unranked

2 citations

Shannon Swift, Renee N. Donahue, Carolina Celades, Yo-Ting Tsai, Molly A. Bingham +11 more

AB014. Bone marrow dyscrasias in autoimmune regulator deficiency: lessons from thymoma and autoimmune polyendocrinopathy-candidiasis ectodermal dystrophy

Mediastinum(2023)10.21037/med-23-ab014

N/A

0DataRank · unranked

0 citations

Shannon Swift, Susan Sansone, Éva Szabó, Chen Zhao, Christine Feierabend +6 more

AB011. Quantification of thymic epithelial tumor volumes through deep learning

Mediastinum(2023)10.21037/med-23-ab011

N/A

0DataRank · unranked

0 citations

Stephanie A. Harmon, James Latanski, Molly A. Bingham, Meredith J. McAdams, Arlene Sirajuddin +8 more

Tregs, gMDSCs, and levels of soluble MICA as prognostic biomarkers for combined NEO-201 and pembrolizumab.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.2530

N/A

0DataRank · unranked

2 citations

Massimo Fantini, Kwong Y. Tsang, Kevin C. Conlon, Charalampos S. Floudas, Azam Ghafoor +8 more